EIF2AK3 and neoplasm: Although ATF4 is known to activate pro-apoptotic factors [33], previous reports have established that failure to fully induce ISR by the eIF2alpha kinases PERK and GCN2 and hence to activate ATF4 reduces tumor cell growth in vitro and in vivo [15, 34, 35].